+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Drug-Eluting Balloon Market to 2027 - Global Analysis and Forecasts by Product Type; End User, and Geography

  • ID: 4987767
  • Report
  • December 2019
  • Region: Global
  • 149 Pages
  • The Insight Partners
UP TO OFF until Jun 30th 2022

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • BD
  • BIOTRONIK SE & Co. KG
  • Concept Medical Inc.
  • Cook Medical
  • Koninklijke Philips N.V.
The global drug-eluting balloon market is expected to reach US$ 1,870.60 Mn in 2027 from US$ 516.65 Mn in 2018. The market is estimated to grow with a CAGR of 15.6% from 2019-2027.

The key factors accounting for the growth of market include significant increase in vascular disease incidences, growing product innovations and rising geriatric population. Whereas, the market is expected to have slow growth due to high cost of procedures and products and stringent regulations for approval during the forecast period.

The drug-eluting balloon market comprises various market leaders and emerging players. Medtronic plc, Boston Scientific Corporation, Cook Medical, and Royal Philips (a part of Koninklijke Philips N.V) are among the market leaders, while there are various emerging players operating in the market. These companies are engaged in the constant development of various medical devices. They have developed these products further to ensure their sustenance in the global market. For instance, in November 2019, Medtronic received the US Food and Drug Administration (FDA) approval for its In. Pact AV drug-coated balloon used in the treatment of failing arteriovenous (AV) access in patients suffering from end-stage renal disease (ESRD), undergoing dialysis. Similarly, Royal Philips has launched two new balloons to its Stellarex portfolio of 0.035-inch, low-dose, drug-coated balloons; the additions include 200mm and 150mm Stellarex 0.035-inch low-dose drug-coated balloons. The products have received FDA approval for the treatment of de novo and restenotic lesions in native superficial femoral or popliteal arteries in upper legs.

Such launches of innovative products by market leaders and new players are driving the growth of the drug-eluting balloon market. This is mainly attributed to the fact that these products have expanded treatment options for physicians to treat peripheral artery diseases (PADs), cardiovascular conditions, and renal artery conditions, and so on.

The drug-eluting balloon market is segmented on the basis of product type, and end user. The market based on product type segment is classified as coronary drug eluting balloons, peripheral drug eluting balloons and other product types. Based on end user the market is segmented as hospitals, cath labs & cardiac centers, and ambulatory surgical centers.

Reasons to Buy
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the drug-eluting balloon market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global drug-eluting balloon market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • BD
  • BIOTRONIK SE & Co. KG
  • Concept Medical Inc.
  • Cook Medical
  • Koninklijke Philips N.V.

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Drug-Eluting Balloon Market - By Product Type
1.3.2 Global Drug-Eluting Balloon Market - By End User
1.3.3 Global Drug-Eluting Balloon Market - By Geography
2. Drug-Eluting Balloon Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Drug-Eluting Balloon- Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America Drug-Eluting Balloon Market - PEST Analysis
4.2.2 Europe Drug-Eluting Balloon Market- PEST Analysis
4.2.3 Asia Pacific Drug-Eluting Balloon Market - PEST Analysis
4.2.4 Middle East & Africa Drug-Eluting Balloon Market - PEST Analysis
4.2.5 South & Central America Drug-Eluting Balloon Market - PEST Analysis
4.3 Expert Opinion
5. Drug-Eluting Balloon Market - Key Dynamics
5.1 Key Drivers
5.1.1 Significantly Rising Vascular Disease Incidences
5.1.2 Growing Product Innovations and Launches
5.1.3 Rising Geriatric Population
5.2 Key Restraints
5.2.1 High Cost of Procedures and Products
5.2.2 Stringent Regulations For Approval
5.3 Key Opportunities
5.3.1 Rising Use of Drug-eluting Balloons Over Drug Eluting Stents
5.4 Current Trends
5.4.1 Introduction of DCB Therapy
5.5 Impact Analysis
6. Drug-Eluting Balloon Market - Global Analysis
6.1 Global Drug-Eluting Balloon Market Revenue Forecast And Analysis
6.2 Global Drug-Eluting Balloon Market, By Geography - Forecast And Analysis
6.3 Positioning Of Key Players
7. Drug-Eluting Balloon Market Analysis and Forecast to 2027 - Product Type
7.1 Overview
7.2 Global Drug-Eluting Balloon Market, By Product Type, 2018 & 2027 (%)
7.3 Coronary Drug-Eluting Balloons
7.3.1 Overview
7.3.2 Coronary Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Peripheral Drug-Eluting Balloons
7.4.1 Overview
7.4.2 Peripheral Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
7.5 Other Product Types
7.5.1 Overview
7.5.2 Other Product Types Market Revenue and Forecast to 2027 (US$ Mn)
8. Drug-Eluting Balloon Market Analysis and Forecast to 2027 - End User
8.1 Overview
8.2 Global Drug-Eluting Balloon Market, By End User, 2018 & 2027 (%)
8.3 Hospitals
8.3.1 Overview
8.3.2 Hospitals Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Cath Labs and Cardiac Centers
8.4.1 Overview
8.4.2 Cath Labs & Cardiac Centers Market Revenue and Forecast to 2027 (US$ Mn)
8.5 Ambulatory Surgical Centers
8.5.1 Overview
8.5.2 Ambulatory Surgical Centers Market Revenue and Forecast to 2027 (US$ Mn)
9. Drug-Eluting Balloon Market Revenue And Forecast To 2027 - Geographical Analysis
9.1 North America Drug-Eluting Balloon Market Revenue and Forecast To 2027
9.1.1 Overview
9.1.2 North America Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
9.1.3 North America Drug-Eluting Balloon Market Revenue and Forecast to 2027, By Product Type (US$ Mn)
9.1.4 North America Drug-Eluting Balloon Market Revenue and Forecast To 2027, By End User (US$ Mn)
9.1.5 North America Drug-Eluting Balloon Market Revenue and Forecast to 2027, By Country (%)
9.1.6 US Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
9.1.6.1 US Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
9.1.6.2 US Drug-Eluting Balloon Market Revenue and Forecast to 2027, By Product Type (US$ Mn)
9.1.6.3 US Drug-Eluting Balloon Market Revenue and Forecast to 2027, By End User (US$ Mn)
9.1.7 Canada Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
9.1.7.1 Canada Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
9.1.7.2 Canada Drug-Eluting Balloon Market Revenue and Forecast to 2027, By Product Type (US$ Mn)
9.1.7.3 Canada Drug-Eluting Balloon Market Revenue and Forecast to 2027, By End User (US$ Mn)
9.1.8 Mexico Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
9.1.8.1 Mexico Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
9.1.8.2 Mexico Drug-Eluting Balloon Market Revenue and Forecast to 2027, By Product Type (US$ Mn)
9.1.8.3 Mexico Drug-Eluting Balloon Market Revenue and Forecast to 2027, By End User (US$ Mn)
9.2 Europe Drug-Eluting Balloon Market Revenue and Forecast To 2027
9.2.1 Overview
9.2.2 Europe Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
9.2.3 Europe Drug-Eluting Balloon Market Revenue and Forecast to 2027, By Product Type (US$ Mn)
9.2.4 Europe Drug-Eluting Balloon Market Revenue and Forecast To 2027, By End User (US$ Mn)
9.2.5 Europe Drug-Eluting Balloon Market Revenue and Forecast to 2027, By Country (%)
9.2.6 Germany Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
9.2.6.1 Germany Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
9.2.6.2 Germany Drug-Eluting Balloon Market Revenue and Forecast to 2027, By Product Type (US$ Mn)
9.2.6.3 Germany Drug-Eluting Balloon Market Revenue and Forecast to 2027, By End User (US$ Mn)
9.2.7 UK Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
9.2.7.1 UK Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
9.2.7.2 UK Drug-Eluting Balloon Market Revenue and Forecast to 2027, By Product Type (US$ Mn)
9.2.7.3 UK Drug-Eluting Balloon Market Revenue and Forecast to 2027, By End User (US$ Mn)
9.2.8 France Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
9.2.8.1 France Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
9.2.8.2 France Drug-Eluting Balloon Market Revenue and Forecast to 2027, By Product Type (US$ Mn)
9.2.8.3 France Drug-Eluting Balloon Market Revenue and Forecast to 2027, By End User (US$ Mn)
9.2.9 Spain Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
9.2.9.1 Spain Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
9.2.9.2 Spain Drug-Eluting Balloon Market Revenue and Forecast to 2027, By Product Type (US$ Mn)
9.2.9.3 Spain Drug-Eluting Balloon Market Revenue and Forecast to 2027, By End User (US$ Mn)
9.2.10 Italy Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
9.2.10.1 Italy Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
9.2.10.2 Italy Drug-Eluting Balloon Market Revenue and Forecast to 2027, By Product Type (US$ Mn)
9.2.10.3 Italy Drug-Eluting Balloon Market Revenue and Forecast to 2027, By End User (US$ Mn)
9.3 Asia Pacific Drug-Eluting Balloon Market Revenue and Forecast To 2027
9.3.1 Overview
9.3.2 Asia Pacific Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
9.3.3 Asia Pacific Drug-Eluting Balloon Market Revenue and Forecast to 2027, By Product Type (US$ Mn)
9.3.4 Asia Pacific Drug-Eluting Balloon Market Revenue and Forecast To 2027, By End User (US$ Mn)
9.3.5 Asia Pacific Drug-Eluting Balloon Market Revenue and Forecast to 2027, By Country (%)
9.3.6 China Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
9.3.6.1 China Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
9.3.6.2 China Drug-Eluting Balloon Market Revenue and Forecast to 2027, By Product Type (US$ Mn)
9.3.6.3 China Drug-Eluting Balloon Market Revenue and Forecast to 2027, By End User (US$ Mn)
9.3.7 Japan Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
9.3.7.1 Japan Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
9.3.7.2 Japan Drug-Eluting Balloon Market Revenue and Forecast to 2027, By Product Type (US$ Mn)
9.3.7.3 Japan Drug-Eluting Balloon Market Revenue and Forecast to 2027, By End User (US$ Mn)
9.3.8 India Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
9.3.8.1 India Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
9.3.8.2 India Drug-Eluting Balloon Market Revenue and Forecast to 2027, By Product Type (US$ Mn)
9.3.8.3 India Drug-Eluting Balloon Market Revenue and Forecast to 2027, By End User (US$ Mn)
9.3.9 South Korea Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
9.3.9.1 South Korea Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
9.3.9.2 South Korea Drug-Eluting Balloon Market Revenue and Forecast to 2027, By Product Type (US$ Mn)
9.3.9.3 South Korea Drug-Eluting Balloon Market Revenue and Forecast to 2027, By End User (US$ Mn)
9.3.10 Australia Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
9.3.10.1 Australia Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
9.3.10.2 Australia Drug-Eluting Balloon Market Revenue and Forecast to 2027, By Product Type (US$ Mn)
9.3.10.3 Australia Drug-Eluting Balloon Market Revenue and Forecast to 2027, By End User (US$ Mn)
9.4 Middle East & Africa Drug-Eluting Balloon Market Revenue and Forecast To 2027
9.4.1 Overview
9.4.2 Middle East & Africa Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
9.4.3 Middle East & Africa Drug-Eluting Balloon Market Revenue and Forecast to 2027, By Product Type (US$ Mn)
9.4.4 Middle East & Africa Drug-Eluting Balloon Market Revenue and Forecast To 2027, By End User (US$ Mn)
9.4.5 Middle East & Africa Drug-Eluting Balloon Market Revenue and Forecast to 2027, By Country (%)
9.4.6 Saudi Arabia Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
9.4.6.1 Saudi Arabia Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
9.4.6.2 Saudi Arabia Drug-Eluting Balloon Market Revenue and Forecast to 2027, By Product Type (US$ Mn)
9.4.6.3 Saudi Arabia Drug-Eluting Balloon Market Revenue and Forecast to 2027, By End User (US$ Mn)
9.4.7 UAE Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
9.4.7.1 UAE Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
9.4.7.2 UAE Drug-Eluting Balloon Market Revenue and Forecast to 2027, By Product Type (US$ Mn)
9.4.7.3 UAE Drug-Eluting Balloon Market Revenue and Forecast to 2027, By End User (US$ Mn)
9.4.8 South Africa Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
9.4.8.1 South Africa Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
9.4.8.2 South Africa Drug-Eluting Balloon Market Revenue and Forecast to 2027, By Product Type (US$ Mn)
9.4.8.3 South Africa Drug-Eluting Balloon Market Revenue and Forecast to 2027, By End User (US$ Mn)
9.5 South and Central America Drug-Eluting Balloon Market Revenue and Forecast To 2027
9.5.1 Overview
9.5.2 South and Central America Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
9.5.3 South and Central America Drug-Eluting Balloon Market Revenue and Forecast to 2027, By Product Type (US$ Mn)
9.5.4 South and Central America Drug-Eluting Balloon Market Revenue and Forecast To 2027, By End User (US$ Mn)
9.5.5 South and Central America Drug-Eluting Balloon Market Revenue and Forecast to 2027, By Country (%)
9.5.6 Brazil Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
9.5.6.1 Brazil Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
9.5.6.2 Brazil Drug-Eluting Balloon Market Revenue and Forecast to 2027, By Product Type (US$ Mn)
9.5.6.3 Brazil Drug-Eluting Balloon Market Revenue and Forecast to 2027, By End User (US$ Mn)
9.5.7 Argentina Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
9.5.7.1 Argentina Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
9.5.7.2 Argentina Drug-Eluting Balloon Market Revenue and Forecast to 2027, By Product Type (US$ Mn)
9.5.7.3 Argentina Drug-Eluting Balloon Market Revenue and Forecast to 2027, By End User (US$ Mn)
10. Drug-Eluting Balloon Market Industry Landscape
10.1 Overview
10.2 Growth Strategies In The Drug-Eluting Balloon Market, 2016-2019
10.3 Developments
10.3.1 Overview
10.3.2 Growth Strategies In The Drug-Eluting Balloon Market, 2016-2019
11. Drug-Eluting Balloon Market-Key Company Profiles
11.1 Koninklijke Philips N.V.
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Financial Overview
11.1.4 Product Portfolio
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Concept Medical Inc.
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Financial Overview
11.2.4 Product Portfolio
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Opto Circuits (India) Limited (Eurocor Tech GmbH)
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Financial Overview
11.3.4 Product Portfolio
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Terumo Corporation
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Financial Overview
11.4.4 Product Portfolio
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 BIOTRONIK SE & Co. KG
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Financial Overview
11.5.4 Product Portfolio
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Innvolution Healthcare Pvt. Ltd.
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Financial Overview
11.6.4 Product Portfolio
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Medtronic Plc
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Financial Overview
11.7.4 Product Portfolio
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 BD
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Financial Overview
11.8.4 Product Portfolio
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Boston Scientific Corporation
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Financial Overview
11.9.4 Product Portfolio
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Cook Medical
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Financial Overview
11.10.4 Product Portfolio
11.10.5 SWOT Analysis
11.10.6 Key Developments
11.11 B. Braun Melsungen AG
11.11.1 Key Facts
11.11.2 Business Description
11.11.3 Financial Overview
11.11.4 Product Portfolio
11.11.5 SWOT Analysis
11.11.6 Key Developments
12. Appendix
12.1 About the Publisher
12.2 Glossary of Terms
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Koninklijke Philips N.V.
  • Concept Medical Inc.
  • Opto Circuits (India) Limited (Eurocor Tech GmbH)
  • Terumo Corporation
  • BIOTRONIK SE & Co. KG
  • Innvolution Healthcare Pvt. Ltd.
  • Medtronic Plc
  • BD
  • Boston Scientific Corporation
  • Cook Medical
  • B. Braun Melsungen AG
Note: Product cover images may vary from those shown